Rebalix
JPMorgan · sheet of 5 September 2026
JPMorgan · sheet of 5 September 2026ETF sheet · official issuer and register data
BetaBuilders US Equity UCITS ETF
BBUD · IE00BJK9H860 · class JPM - USD (dist) · USD · domicile Ireland
Equity · GlobalSFDR art. 6
Index tracked: MSUTMENU
- TER
- 0.04%+ trans. 0.00%
- Fund size
- 83 m EUR
- Tracking difference
- —not computable
- 🇮🇹 tax rate
- 26.00%white list 0.00%
- Replication
- Physical (full replication)
- Income
- Distributingquarterly
Launch 3 Apr 2019 · costs from the KID as of 2 Sept 2026 · 468 securities held · 4 venues (ESMA register)
The fund’s objective — in the issuer’s words
From the Key Information Document (KID) · 4 Aug 2026
Investment Objective: The Sub-Fund seeks to provide returns that correspond with those of the Index by investing primarily in US stocks. The Sub-Fund may, for efficient portfolio management purposes, use financial derivative instruments.
Investment Policy:
The Sub-Fund pursues a passively managed (index tracking) strategy. USD is the base currency of the Sub-Fund. The Sub-Fund aims to track the performance of the Index as closely as possible, regardless of whether the Index level rises or falls, while seeking to minimise as far as possible the tracking…
Performance since series start (in euro) — base 100
3 Apr 2019 → 3 Sept 2026 · dividends reinvested where declared by the issuer · converted at ECB rates
Returns in euro
| 1 year | +21.7% |
| 3 years | +65.3% |
| 5 years | +80.7% |
| 10 years | series too young |
| Since series start | +184.8% |
Risk · 1 / 3 / 5 years
| Volatility (ann.) | 12.72% | 14.86% | 17.02% |
| Max drawdown | −9.40% | −19.07% | −26.56% |
| Sharpe | 1.25 | 1.04 | 0.53 |
| Sortino | 1.81 | 1.51 | 0.75 |
Sharpe/Sortino: risk-free = ECB MRO avg; nominal volatility
Rebalix · BBUD · IE00BJK9H8601
RebalixBBUD · IE00BJK9H860 · sheet of 5 September 2026
Tracking difference — year by year
Fund minus index, complete calendar years
Not honestly computable: index series not published by the issuer
Distributions · per share, in USD
Frequency: quarterly · last 12 months: 0.7163 USD (1.07% of NAV) · last ex-date 9 Jul 2026
| Year | Payments | Total (USD) | Dividend yield |
|---|---|---|---|
| 2026 | 3 | 0.4343 | — |
| 2025 | 4 | 0.6555 | +1.28% |
| 2024 | 4 | 0.5214 | +1.25% |
| 2023 | 4 | 0.5369 | +1.61% |
| 2022 | 4 | 0.4856 | +1.16% |
Dividend yield: the year’s distributions over the share value (NAV) at the start of the year.
Holdings
Portfolio as declared by the issuer · 1 Sept 2026 · 468 securities · top-10 weight = 37.5%
| Top holdings | Weight |
|---|---|
| 7.8% | |
| 7.3% | |
| 5.7% | |
| 3.8% | |
| 3.0% | |
| 2.6% | |
| 2.4% | |
| 1.9% | |
| 1.6% | |
| 1.5% |
Countries (% of fund)
Listing venues
ESMA register (FIRDS) and official exchange lists
BBUD · Börse Düsseldorf, Börse Hamburg, Börse Hannover, Tradegate Exchange
+ 6 unmapped venues (MTF, RFQ, professional)
Official documents
Clickable links in the PDF
The live sheet, always up to date
rebalix.com/en/etf/IE00BJK9H860
Series, distributions, holdings and documents refresh daily.
rebalix.com/en/etf/IE00BJK9H860
Series, distributions, holdings and documents refresh daily.
Sheet produced on 5 September 2026 · data as of the dates shown section by section. Sources: official issuer documents (KID, factsheet, NAV and total-return series, declared portfolio), ESMA register (FIRDS), European Central Bank (FX), Italian tax authority / issuer (white-list share). Public methodology: rebalix.com/en/methodology. “—” = not published by the source, never estimated.
Informational document generated by rebalix.com: facts only, no recommendations. Not investment advice or investment research under Directive 2014/65/EU (MiFID II), nor an offer or solicitation. Past performance is not indicative of, nor a guarantee of, future results; the value of an investment can go down as well as up. Before any decision read the issuer’s KID and Prospectus; tax treatment depends on individual circumstances. Trademarks and logos belong to their respective owners and only identify the instrument and its issuer: no affiliation, sponsorship or endorsement.
Rebalix · BBUD · IE00BJK9H8602